Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO
Clinical trial NCT01624571 · COMPLETED
Trial details
- NCT number
- NCT01624571
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.